# A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants

> **NCT05537090** · PHASE1 · COMPLETED · sponsor: **BioVersys AG** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BV100
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05537090
- **Lead sponsor:** BioVersys AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05537090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05537090, "A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05537090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*